ZYDUS LIFESCIENCES
Back to Cashflow Statement
|
ZYDUS LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹5,807 Cr | ₹1,995 Cr | ₹-1,779 Cr | ₹-4,400 Cr | ₹-868 Cr |
What is the latest Cash Flow from Financing Activities ratio of ZYDUS LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹5,807 Cr |
| Mar2025 | ₹1,995 Cr |
| Mar2024 | ₹-1,779 Cr |
| Mar2023 | ₹-4,400 Cr |
| Mar2022 | ₹-868 Cr |
How is Cash Flow from Financing Activities of ZYDUS LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,807 Cr | 191.03 | |
| Mar2025 | ₹1,995 Cr | Positive | |
| Mar2024 | ₹-1,779 Cr | Negative | |
| Mar2023 | ₹-4,400 Cr | Negative | |
| Mar2022 | ₹-868 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹114,832.2 Cr | -3.2% | 2.9% | 19.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | -3.2% |
2.9% |
19.2% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses